International Clinical Trial: Construction of an Induced Pluripotent Stem Cell (iPSC)-Based Model for Duchenne Muscular Dystrophy (DMD) and Investigation of the Underlying Mechanisms of Cardiomyopathy

Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126646) titled 'Construction of an Induced Pluripotent Stem Cell (iPSC)-Based Model for Duchenne Muscular Dystrophy (DMD) and Investigation of the Underlying Mechanisms of Cardiomyopathy' on June 12.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Children's Hospital of Chongqing Medical University

Condition: Progressive Muscular Dystrophy and Cardiac Involvement

Intervention: the DMD patient group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-20

Target Sample Size: the DMD patient group:10;healthy control group:5;

Countries of Recruitment: China...